Efrat Eliyahu, PhD
About Me
Efrat Eliyahu, PhD, is an Assistant Professor with the Department of Genetics and Genomic Sciences. Dr. Eliyahu's research is focused on understanding how embryonic molecular networks are re-programed during post-natal life and how they may be re-activated in adult organisms. Specifically, her lab studies the role of sphingolipid metabolism in regulating cell survival under optimal physiological conditions and response to stress. She has led development of a novel gene therapy approach to supplement AC enzyme to enable normalization of the levels of ceramide and to prevent ceramide-mediated pathological processes, such as programmed cell death and senescence. The Eliyahu lab has patented several methods for AC delivery and are now advancing to clinical trials for human and veterinary use in multiple areas of healthcare, including reproduction medicine, cardiovascular diseases, and orthopedics.
Mailing Address:
Department of Genetics and Genomic Sciences,
1470 Madison Ave, 8th floor, room 202A
New York, NY 10029
Language
English
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Eliyahu has not yet completed reporting of Industry relationships.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.